The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017: Korea Central Cancer Registry
2
조회
0
다운로드
23
인용
0
참고문헌
키워드
초록
ObjectiveThe three major gynecologic cancers are cervical, endometrial, and ovarian cancer. This study aimed to describe the19-year trends and survival rates in cervical, endometrial, and ovarian cancer in a Korean female population. MethodsWe searched the Korea Central Cancer Registry to identify patients with gynecologic cancer between 1999 and 2017. Age-standardized rates and annual percent changes were calculated. The relative survival rate (RSR) was reported byhistology, age, and stage for each gynecological cancer. ResultsThe total number of cervical, endometrial, primary peritoneal, ovarian epithelial, fallopian tube (POFT) cancer was134,863, with the number of cases increasing every year: 6,077 in 1999 to 8,011 in 2017. The incidence of cervicalcancer has decreased; however, that of POFT and endometrial cancer has increased. The 5-year RSR of cervical, POFT,and endometrial cancer was reported to be 80.8%, 61.4%, and 88.1%, respectively. In the case of cervical cancer,squamous cell carcinoma showed better survival than other histology (82.8% vs. 73.5%). Furthermore, in the case ofendometrial cancer, endometrioid histology had substantially better 5-year RSR than the others (93.2% vs. 76.5%). Contrastingly, in the case of ovarian cancer, serous carcinoma had worse 5-year RSR than other types of histology. ConclusionThe incidence rates for gynecologic cancers increased from 2005 to 2017, with an annual increase of 2.76 per yearuntil 2017. Endometrial cancer had the highest RSR, while ovarian cancer had the lowest. Active cancer screening andthe introduction of effective treatments might have contributed to the improved RSRs of gynecologic cancers.
Abstract
ObjectiveThe three major gynecologic cancers are cervical, endometrial, and ovarian cancer. This study aimed to describe the19-year trends and survival rates in cervical, endometrial, and ovarian cancer in a Korean female population. MethodsWe searched the Korea Central Cancer Registry to identify patients with gynecologic cancer between 1999 and 2017. Age-standardized rates and annual percent changes were calculated. The relative survival rate (RSR) was reported byhistology, age, and stage for each gynecological cancer. ResultsThe total number of cervical, endometrial, primary peritoneal, ovarian epithelial, fallopian tube (POFT) cancer was134,863, with the number of cases increasing every year: 6,077 in 1999 to 8,011 in 2017. The incidence of cervicalcancer has decreased; however, that of POFT and endometrial cancer has increased. The 5-year RSR of cervical, POFT,and endometrial cancer was reported to be 80.8%, 61.4%, and 88.1%, respectively. In the case of cervical cancer,squamous cell carcinoma showed better survival than other histology (82.8% vs. 73.5%). Furthermore, in the case ofendometrial cancer, endometrioid histology had substantially better 5-year RSR than the others (93.2% vs. 76.5%). Contrastingly, in the case of ovarian cancer, serous carcinoma had worse 5-year RSR than other types of histology. ConclusionThe incidence rates for gynecologic cancers increased from 2005 to 2017, with an annual increase of 2.76 per yearuntil 2017. Endometrial cancer had the highest RSR, while ovarian cancer had the lowest. Active cancer screening andthe introduction of effective treatments might have contributed to the improved RSRs of gynecologic cancers.
참고문헌 (29)
- 홍세리, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017", Cancer Research and Treatment, 52(2), pp.335~350 (2020), 대한암학회
- Hai-Rim Shin, "Nationwide Cancer Incidence in Korea, 1999~2001; First Result Using the National Cancer Incidence Database", Cancer Research and Treatment, 37(6), pp.325~331 (2005), 대한암학회
- Chung HH, "Cervical cancer incidence and survival in Korea : 1993-2002", Int J Gynecol Cancer, 16, pp.1833~1838 (2006)
- Chung HH, "Ovarian cancer incidence and survival in Korea : 1993-2002", Int J Gynecol Cancer, 17, pp.595~600 (2007)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016", Cancer Research and Treatment, 51(2), pp.417~430 (2019), 대한암학회
- World Health Organization, "International statistical classification of diseases and related health problems" (1994), World Health Organization Press
- Segi M, "Cancer mortality for selected sites in 24 countries (1950-1957)" (1960), Tohoku University School of Medicine
- National Cancer Institute, "SEER Summary staging manual 2000: codes and coding instructions", National Cancer Institute, ~ (2000)
- Ederer F, "Instructions to IBM 650 programmers in processing survival computations", National Cancer Institute, ~ (1959)
- Oh CM, "Trends in the incidence of in situ and invasive cervical cancer by age group and histological type in Korea from 1993 to 2009", PLoS One, 8, pp.e72012~ (2013)
- 임명철, "Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010", Journal of Gynecologic Oncology, 24(4), pp.298~302 (2013), 대한부인종양학회
- Patel A, "Cervical cancer incidence in young women : a historical and geographic controlled UK regional population study", Br J Cancer, 106, pp.1753~1759 (2012)
- 박종섭, "한국 젊은 여성의 성생활 양상; HPV예방 백신 도입을 위한 예비 연구", Journal of Gynecologic Oncology, 18(3), pp.209~218 (2007), 대한부인종양학회
- 김영탁, "Current status of cervical cancer and HPV infection in Korea", Journal of Gynecologic Oncology, 20(1), pp.1~7 (2009), 대한부인종양학회
- Hunn J, "Ovarian cancer: etiology, risk factors, and epidemiology", Clin Obstet Gynecol, 55, pp.3~23 (2012)
- Calle EE, "Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults", N Engl J Med, 348, pp.1625~1638 (2003)
- Lee JY, "Changes in ovarian cancer survival during the 20years before the era of targeted therapy", BMC Cancer, 18, pp.601~ (2018)
- 김세익, "Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012", Journal of Gynecologic Oncology, 27(1), pp.1~10 (2016), 대한부인종양학회
- 백인경, "Forecasting obesity prevalence in Korean adults for the years 2020 and 2030 by the analysis of contributing factors", Nutrition Research and Practice, 12(3), pp.251~257 (2018), 한국영양학회
- Wise MR, "Obesity and endometrial hyperplasia and cancer in premenopausal women : a systematic review", Am J Obstet Gynecol, 214, pp.689~ (2016)
- Sung H, "Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry", Lancet Public Health, 4, pp.e137~e147 (2019)
- 이다용, "Associations between metabolic syndrome and gynecologic cancer", Obstetrics & Gynecology Science, 63(3), pp.215~224 (2020), 대한산부인과학회[DOI]
- Song JE, "Factors related to low birth rate among married women in Korea", PLoS One, 13, pp.e0194597~ (2018)
- Raglan O, "Risk factors for endometrial cancer : an umbrella review of the literature", Int J Cancer, 145, pp.1719~1730 (2019)
- 박형준, "Trends and Cut-Point Changes in Obesity Parameters by Age Groups Considering Metabolic Syndrome", Journal of Korean Medical Science, 33(7), pp.1~10 (2018), 대한의학회
- Bjørge T, "Body size in relation to cancer of the uterine corpus in 1 million Norwegian women", Int J Cancer, 120, pp.378~383 (2007)
- Parsons LHP, "The prevalence of occult endometrial cancer in women undergoing hysterectomy for benign indications", Eur J Obstet Gynecol Reprod Biol, 223, pp.108~112 (2018)
- Desai VB, "Prevalence, characteristics, and risk factors of occult uterine cancer in presumed benign hysterectomy", Am J Obstet Gynecol, 221, pp.39~ (2019)
- Frost JA, "Lymphadenectomy for the management of endometrial cancer", Cochrane Database Syst Rev, 10, pp.CD007585~ (2017)